Detection rate of GRPR-targeted PET in PSMA-negative prostate cancer in biochemical recurrence as a function of serum PSA and Gleason score

Category Primary study
Registry of TrialsGerman Clinical Trials Register
Year 2023
This article has no abstract
Epistemonikos ID: a65e896a6218f9809d104bac86914f4406f28ffb
First added on: Apr 10, 2025